The same goes for people with a condition called gastroparesis, which affects stomach nerves and muscles, and those susceptible to medullary thyroid cancer
This analysis confirmed a significant association between GLP-1 RAs and these NAEs (ROR 1.44, 95% CI 1.411.46), with variation observed across different GLP-1 RAs (Fig
Rationale and design of a multicenter chronic kidney disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
It works on both the GIP and GLP-1 receptor pathways, which is why many patients group it with GLP-1 weight-loss injections
While initially approved for Type 2 diabetes, its increasingly prescribed off-label for weight loss due to its strong results
The 48-week data point At 48 weeks, participants in the 12 mg group had lost an average of 24.2% of body weight and the trajectory had not fully plateaued